THE USE OF HYALURONIC ACID IN GONARTHROSIS IN REAL CLINICAL PRACTICE
https://doi.org/10.14341/osteo2015118-22
Abstract
Objectives. To assess the frequency and preferences when assigning intraarticular therapy with hyaluronic acid (HA) in knee оsteoarthritis (ОА) in clinical practice. Material and methods. The analysis of 200 patient records with knee OA treated at the regional center of rheumatology to assess the frequency and spectrum assignment of НА, profile of patients, who were prescribed HA, and its effectiveness. To assess the opinions of rheumatologists on intraarticular therapy with НА we conducted an anonymous questionnaire of 20 rheumatologists of Ekaterinburg. Results. The analysis showed that intraarticular НА therapy was recommended by rheumatologists to 46% of patients with knee ОА, of which the treatment was performed in only 35%. Patients who received treatment were older and more often took NSAIDs and symptomatic slow-acting drugs. Intra-articular НА therapy was effective in 69% of patients. НА with higher molecular weight were more effective, although rheumatologists prefer НА with low molecular weight. Conclusion. In clinical practice, НА is used widely in the treatment of knee ОА, a positive effect from the treatment noted in more than a half of patients.
References
1. Заболеваемость населения России в 2009 году. Статистические материалы Министерства здравоохранения и социального развития Российской Федерации. Часть II. М., 2010; 143-45.
2. Фоломеева О.М., Галушко Е.А., Эрдес Ш.Ф. Распространенность ревматических заболеваний в популяциях взрослого населения России и США Научно-практическая ревматология. 2008; 4: 4-13.
3. Peat G., McCarney R., Croft Р. Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann. Rheum. Dis. 2001; 60: 91-7.
4. Галушко Е.А., Большакова ТЮ., Виноградова И.Б., Иванова О.Н., Лесняк О.М., Меньшикова Л.В., Петрачкова Т.Н., Эрдес Ш.Ф. Структура ревматических заболеваний среди взрослого населения России по данным эпидемиологического исследования. Научно-практическая ревматология. 2009; 1: 1-17.
5. Roth S.H. Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety. Clin. interven. Aging. 2011; 6: 125-31.
6. Cheng O.T., Souzdalnitski D., Vrooman B., Cheng J. Evidence-based knee injections for the management of arthritis. Pain Med. 2012; 13(6): 740-53.
7. Gigantea A., Callegari L. The role of intraarticular hyaluronan (Sinovial) in the treatment of osteoarthritis. Rheumatology International. 2011; 31(4): 427-44.
8. Roque V., Agre M., Barroso J., Brito I. Managing knee ostheoarthritis: efficacy of hyaluronic acid injections. Acta Reumatol. Port. 2013; 38(3): 154-61.
9. Miller L.E., Block J.E. US-Approved Intra-Articular Hyaluronic Acid Injections are Safe and Effective in Patients with Knee Osteoarthritis: Systematic Review and Meta-Analysis of Randomized, Saline-Controlled Trials. Clin. Med. Insights Arthritis Musculoskelet. Disord. 2013; 1(6): 57-63.
10. Bannuru R.R., Schmid C.H., Kent D.M., Vaysbrot E.E., Wong J.B., McAlindon T.E. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann. Intern. Med. 2015; 162(1): 46-64.
11. Аникин С.Г., Алексеева Л.И., Зайцева Е.М., Кашеварова Н.Г, Короткова Т.А., Шарапова Е.П. Исследование эффективности, переносимости и безопасности гиалуроновой кислоты у пациентов с остеоартрозом коленных суставов. Лечащий врач. 2014; 12: 92-5.
12. Jordan K.M., Arden N.K., Doherty M., Bannwarth B., Bijlsma J.W., Dieppe P., Gunther K., Hauselmann H., Herrero-Beaumont G., Kaklamanis P., Lohmander S., Leeb B., Lequesne M., Mazieres B., Martin-Mola E., Pavelka K., Pendleton A., Punzi L., Serni U., Swoboda B., Verbruggen G., Zimmerman-Gorska I., Dougados M. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann. Rheum. Dis. 2003; 62: 1145-55.
13. Zhang W., Nuki G., Moskowitz R.W., Abramson S., Altman R.D., Arden N.K., Bierma-Zeinstra S., Brandt K.D., Croft P., Doherty M., Dougados M., Hochberg M., Hunter D.J., Kwoh K., Lohmander L.S., Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010; 18(4): 476-99.
14. Hochberg M.C., Altman R.D., April K.T., Benkhalti M., Guyatt G., McGowan J., Towheed T., Welch V., Wells G., Tugwell P. American College of Rheumatology 2012. Recommendations for the Use of Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care & Research. 2012; 64(4): 465-74.
15. Общероссийская общественная организация «Ассоциация ревматологов России». Федеральные клинические рекомендации по диагностике и лечению остеоартроза. 2013; 17.
16. Bruyère O., Cooper С., Pelletier J.P., Branco J., Brandi M.L., Guillemin F., Hochberg M.C., Kanis J.F., Kvien T.K., Martel-Pelletier J., Rizzoli R., Silverman S., Reginster J.Y. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Seminars in Arthritis & Rheumatism. 2014; 44(3): 253-63.
17. Migliore А., Bizzi E., Herrero-Beaumont J., Petrella R.J., Raman R., Chevalier X. The discrepancy between recommendations and clinical practice for viscosupplementation in osteoarthritis: mind the gap! European Review for Medical and Pharmacological Sciences. 2015; 19: 1124-29.
18. Wobig M., Bach G., Beks P., Dickhut A., Runzheimer J., Schwieger G., Vetter G., Balazs E. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin. Ther. 1999; 21(9): 1549-62.
19. Pavelka K., Uebelhart D. Efficacy evaluation of highly purified intra-articular hyaluronic acid (Sinovial(®)) vs hylan G-F20 (Synvisc(®)) in the treatment of symptomatic knee osteoarthritis. A double-blind, controlled, randomized, parallel-group non-inferiority study. Osteoarthritis Cartilage. 2011; 19(11): 1294-1300.
20. Maheu E., Zaim M., Appelboom T., Jeka S., Trc T., Berenbaum F., Maasalu K., Berenbaum F. Comparative efficacy and safety of two different molecular weight (MW) hyaluronans F60027 and Hylan G-F20 in symptomatic osteoarthritis of the knee (KOA). Results of a non inferiority, prospective, randomized, controlled trial. Clin. Exp. Rheumatol. 2011; 29(3): 527-35.
21. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines/ Recommendation for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum. 2000; 43(9): 1905-15.
22. McAlindon T.E., Bannuru R.R., Sullivan M.C., Arden N.K., Berenbaum F., Bierma-Zeinstra S.M., Hawker G.A., Henrotin Y., Hunter D.J, Kawaguchi H., Kwoh K., Lohmander S., Rannou F., Roos E.M., Underwood M. OARSI guidelines for the non-surgical management of knee Оsteoarthritis. Osteoarthritis and Cartilage. 2014; 22: 363-88.
23. Altman R.D. Non-avian-derived hyaluronan for the treatment of osteoarthritis of the knee. Expert Rev Clin Immunol. 2010; 6(1): 21-7.
Review
For citations:
Vaskova N.V., Evstigneeva L.P., Ivashova I.G., Kuznecova N.M., Gan E.Y., Lesnyak O.M. THE USE OF HYALURONIC ACID IN GONARTHROSIS IN REAL CLINICAL PRACTICE. Osteoporosis and Bone Diseases. 2015;18(1):18-22. (In Russ.) https://doi.org/10.14341/osteo2015118-22
Views:
3046
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
